Skip to content
OpenCapital
Get started

Alignment Healthcare ALHC Pharmacy rebate receivables

Other financials

Income statement

See full
Revenue$1.2B+33.3%
Operating income$15.5M+387%
Net income$11.4M+225%
EPS (diluted)$0.05+200%

Balance sheet

See full
Cash & equivalents$707.7M+57.9%
Total debt$323.6M+0.5%
Total equity$206.9M+91.3%
Total assets$1.3B+40.9%

Cash flow

See full
Operating cash flow$128.7M+674%
CapEx$7.4M-10.8%
Free cash flow$121.3M+1,350%

Valuation

See full
Market cap$4.52B+0.8%

Profitability

See full
Operating margin0.1%0.0pp
Net margin0.5%+0.2pp
FCF margin4.1%—

Returns & leverage

See full
Return on equity12.6%+6.8pp
Debt / equity1.6×-1.4×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Alignment Healthcare in its filing.

Tagged under the XBRL concept alhc:PharmacyRebateReceivables.

The official record: Alignment Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Alignment Healthcare's pharmacy rebate receivables?
Alignment Healthcare (ALHC) reported pharmacy rebate receivables of $161.35M in Q1 2026.
How has Alignment Healthcare's pharmacy rebate receivables changed year-over-year?
Alignment Healthcare's pharmacy rebate receivables increased by 26.9% year-over-year, from $127.15M to $161.35M.
What is the long-term trend for Alignment Healthcare's pharmacy rebate receivables?
Over 2 years (2023 to 2025), Alignment Healthcare's pharmacy rebate receivables has grown at a 53.7% compound annual growth rate (CAGR), from $75.89M to $179.2M.